Wanaque, NJ, United States of America

Peter S Belica

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter S Belica. Retrieved from https://idiyas.com/inventor/peter-s-belica

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter S. Belica

Introduction

Peter S. Belica is a notable inventor based in Wanaque, NJ (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of important compounds. His work has led to advancements that are crucial for various applications in pharmaceuticals.

Latest Patents

Peter S. Belica holds 1 patent for his innovative work titled "Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine." This patent describes a novel method for the synthesis of 2',3'-dideoxycytidine, which involves bromoacetylating cytidine to yield novel intermediates. These intermediates are then reduced and hydrogenated through unique procedures to produce the desired compound.

Career Highlights

Belica is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His role at the company has allowed him to focus on research and development, contributing to the advancement of medicinal chemistry.

Collaborations

Throughout his career, Peter has collaborated with esteemed colleagues such as Percy Sarwood Manchand and Tai-Nang Huang. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Peter S. Belica's contributions to the field of chemistry and his innovative patent demonstrate his commitment to advancing pharmaceutical science. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…